Target intelligence / Profile preview

Transfer RNA with GU anticodon

Molecular classification
Other
01

Overview

Transfer RNA (tRNA) molecules with GU anticodons enable recognition of multiple codons through "wobble" base pairing at the third codon position. According to the wobble hypothesis, when the first nucleotide of a tRNA anticodon is G or U, it can pair with more than one mRNA base during translation (e.g., G can pair with C or U, and U can pair with A or G)[4]. This property reduces the number of distinct tRNAs required to decode all codons and allows for efficient translation but can increase tolerance for certain types of codon-anticodon mismatches, which may result in non-standard amino acid incorporation[1][3]. tRNAs are not generally considered therapeutic targets or specific receptors, enzymes, or transporters. Instead, they are essential components of the translation machinery[2][4]. While synthetic or engineered tRNAs have been studied for translational suppression or recoding purposes, natural tRNAs with GU anticodons are not themselves classified as drug targets or disease biomarkers[1][3][5]. **Note:** This query describes a structural feature of a class of tRNAs, not a specific gene, protein, or canonical drug target. The "target" as requested is thus ambiguous, lacks a standardized singular target entity, and does not match the conventions used for classical therapeutic molecular targets.

Other names
tRNA with GU anticodonGU-anticodon tRNAGU wobble tRNA
02

Biological functions

TranslationCodon recognitionWobble pairing
03

Disease associations

Other

Beyond the preview

Go deeper on Transfer RNA with GU anticodon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transfer RNA with GU anticodon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call